Merit Medical shareholders elect three directors, approve say-on-pay and auditor ratification

The results of the voting on a non-binding advisory proposal to approve the frequency of votes on compensation of the Company’s named executive officers were as follows: ​ 1 Year 2 Years 3 Years Abstain 49,802,382 ​ 30,676 ​ 2,069,476 ​ 17,601 ​ ​ Accordingly, a majority of votes cast with respect to the frequency of votes on compensation proposal were “for” 1 year, as disclosed in the Proxy Statement.

The results of the voting on a non-binding advisory proposal to approve the compensation of the Company’s named executive officers were as follows: ​ For Against Abstain Broker Non-Votes 49,890,989 ​ 1,994,786 ​ 34,360 ​ 1,204,431 ​ Accordingly, a majority of votes cast with respect to the advisory “say-on-pay” proposal were “for” approval of the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement.

The voting results with respect to the proposal to ratify the appointment of Deloitte & Touche LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 were as follows: ​ For Against Abstain 50,876,135 ​ 2,211,426 ​ 37,005 ​ Accordingly, the Company’s shareholders ratified the appointment of Deloitte and Touche LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.

The votes cast for or withheld for each director nominee were as follows: ​ Director Nominee For Against ​ Abstain ​ Broker Non-Votes Lonny J. Carpenter 50,024,416 ​ 1,862,957 ​ 32,762 ​ 1,204,431 David K. Floyd 49,834,579 ​ 2,052,794 ​ 32,762 ​ 1,204,431 Lynne N. Ward 49,228,089 ​ 2,657,197 ​ 34,849 ​ 1,204,431 ​ Accordingly, each of the three nominees listed above was elected to serve as a director of the Company until the 2026 Annual Meeting of Shareholders and until his or her successor is duly elected and qualified.